Clinical Trials Browser

INDUSTRY × STA 9090 × Tumor-Agnostic × Clear all

NCT01183364 2014-09-19

A Dose Escalation Study of STA-9090 and Docetaxel in Patients With Solid Tumors

Phase 1 Completed

Neoplasms

NCT00687934 2014-09-18

Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors

Phase 1 Completed

Neoplasm Metastasis

NCT00688116 2014-09-18

Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors

Phase 1 Unknown

Neoplasm Metastasis